Literature DB >> 31966460

Expression of Tiam1 and Rac1 proteins in renal cell carcinoma and its clinical-pathological features.

Guang Shan1, Tian Tang2, Huijun Qian1, Yue Xia1.   

Abstract

PURPOSE: To explore the connections between Tiam1 and Rac1 expression in renal cell carcinoma (RCC), and its pathological type, grading, invasion and metastasis.
METHODS: Tiam1 and Rac1 expression was measured in 60 specimens of RCC (including 42 clear cell cases, 12 papillary cases, and 6 chromophobe cases) and a 10-specimen control group using quantum dots IHC labeling, complete with clinical and pathological records, dated 2008 to 2014, were taken from the archives of the Department of Pathology, People's Hospital of Wuhan University. The expressions of Tiam1 and Rac1 proteins in specimens were measured using immunohistochemical (IHC) and quantum dots-labeling methods to examine their relationships to the clinical and pathological characteristics of RCC. The HIPAS-1000 software was used to quantitatively analyze on the results to obtain absorbance and positive area ratio (PAR) values, and SPSS 15.0 was used to perform single-factor analysis of variance and q verification. Spearman's rank correlation test is used to verify the correlation between absorbance and PAR of the two proteins.
RESULTS: 1. QDs IHC staining. Tiam1 and Rac1 expression is high in RCC, and low in surrounding tissues (P<0.05). 2. Expression levels of both proteins show no correlation with patient sex, age, or tumor size (P>0.05), yet correlate with the differentiation, stage, and lymphatic metastasis of tumors (P<0.05). Spearman's test shows a positive correlation between the expression levels of Tiam1 and Rac1 in RCC tissues (r=0.425, P<0.05).
CONCLUSION: 1. Abnormal Tiam1 and Rac1 expression may be an early molecular event in RCC, suggesting they are carcinogens related to proto-oncogenes. 2. Tiam1 and Rac1 expression levels correlate with the differentiation, stage, and lymphatic metastasis of RCC, suggesting they play important roles in its invasion and metastasis. 3. The expression levels of Tiam1 and Rac1 are positively correlated within RCC, suggesting a synergy between the two in controlling its pathogenesis and development. IJCEP
Copyright © 2017.

Entities:  

Keywords:  Rac1; Renal cell carcinoma; Tiam1; immunohistochemistry; pathological feature; quantum dots

Year:  2017        PMID: 31966460      PMCID: PMC6965875     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  3 in total

1.  Fibulin-3 sponges Tiam1 to manipulate MMP-7 activity through β-catenin signaling in oral squamous cell carcinoma.

Authors:  Honglei Guo; Yangyang Ji; Bo Zhang; Xin Huang
Journal:  Med Oncol       Date:  2022-07-19       Impact factor: 3.738

2.  Up-Regulation of Tiam1 Promotes the Radioresistance of Laryngeal Squamous Cell Carcinoma Through Activation of the JNK/ATF-2 Signaling Pathway.

Authors:  Shuang Wang; Weiyu Zhu; Lei Ouyang; Jingkun Li; Shisheng Li; Xinming Yang
Journal:  Onco Targets Ther       Date:  2020-07-21       Impact factor: 4.147

Review 3.  Rac1, A Potential Target for Tumor Therapy.

Authors:  Jiaxin Liang; Linda Oyang; Shan Rao; Yaqian Han; Xia Luo; Pin Yi; Jinguan Lin; Longzheng Xia; Jiaqi Hu; Shiming Tan; Lu Tang; Qing Pan; Yanyan Tang; Yujuan Zhou; Qianjin Liao
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.